About half of the US FDA's user fee goal dates in September 2025 are for rare conditions, a high priority of the agency's new leadership. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
